ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » District of Columbia » Internal Medicine

Top Internal Medicine Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDWIN CHAPMAN M.D.

Internal Medicine

2,881

$364K

137
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

31%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 29%

$126
Average prescription price

Avg: $77

CESAR TORRES MD

Internal Medicine

2,869

$155K

227
197 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$54
Average prescription price

Avg: $77

ANDREW LEE D.O.

Internal Medicine

2,846

$224K

213
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$79
Average prescription price

Avg: $77

POUNEH NOURI MD

Internal Medicine

2,817

$366K

168
63 are 65+

26%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$130
Average prescription price

Avg: $77

ABBIEMAE MILLER MD

Internal Medicine

2,787

$193K

274
137 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$69
Average prescription price

Avg: $77

MARK STRONG M.D.

Internal Medicine

2,685

$139K

176
127 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $77

MELISSA KLEIN M.D.

Internal Medicine

2,677

$178K

236
153 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $77

FARZAM AYAZI

Internal Medicine

2,626

$170K

188
98 are 65+

23%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $77

INDER JAIN MD

Internal Medicine

2,558

$110K

254
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$43
Average prescription price

Avg: $77

LISA LEE MD

Internal Medicine

2,542

$141K

214
193 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $77

RONALD DISTAJO M.D., M.P.H.

Internal Medicine

2,535

$118K

244
125 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 29%

$47
Average prescription price

Avg: $77

GORDON RAMSAY M.D.

Internal Medicine

2,531

$151K

138
75 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $77

ASHESH PATEL MD

Internal Medicine

2,514

$233K

164
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 29%

$93
Average prescription price

Avg: $77

KEVIN NEALON MD

Internal Medicine

2,483

$229K

155
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 29%

$92
Average prescription price

Avg: $77

DANIEL YOUNG MD

Internal Medicine

2,414

$272K

110
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 29%

$113
Average prescription price

Avg: $77

LESLIE KECK MD

Internal Medicine

2,404

$98.4K

136
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 29%

$41
Average prescription price

Avg: $77

MARY RESTIFO M.D.

Internal Medicine

2,387

$165K

176
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$69
Average prescription price

Avg: $77

JON WISEMAN M.D.

Internal Medicine

2,386

$213K

167
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$89
Average prescription price

Avg: $77

KATALIN ROTH M.D.

Internal Medicine

2,383

$145K

214
200 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $77

KRISTIN YAMAMOTO M.D.

Internal Medicine

2,310

$162K

164
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $77

ANDRES MENDEZ MUNOZ MD

Internal Medicine

2,295

$122K

231
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$53
Average prescription price

Avg: $77

MICHAEL NEWMAN MD

Internal Medicine

2,291

$244K

214
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 29%

$106
Average prescription price

Avg: $77

NICOLE RICHARDSON DO

Internal Medicine

2,288

$120K

211
177 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $77

SOS MBOIJANA M.D.

Internal Medicine

2,252

$117K

226
199 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $77

DANNY MAMODESENE M.D.,

Internal Medicine

2,202

$102K

224
115 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 29%

$46
Average prescription price

Avg: $77

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank